Corpus Pharmaceuticals India Private Limited
About Corpus Pharmaceuticals India Private Limited
Data last updated:
Corpus Pharmaceuticals India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical appliances and instruments segment of the healthcare sector. It was incorporated on 25 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33100DL2018PTC339418. Its GSTIN is 06AAHCC7619R1ZZ (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vijender Singh and Prashant.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H. No. A – 29/1 GF Panchsheel Vihar Khirki Malviya Nagar, New Delhi, Delhi, India – 110017.
As per the financials filed for FY 2020, the company reported a revenue of ₹6.98 Lakh, a growth of 100% compared to the previous year. For the same year it recorded a net loss of ₹1,748 (net margin -0.3%) and EBITDA of -₹1,748 (EBITDA margin -0.3%).
Company details
Contact details
Corpus Pharmaceuticals India Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressH. No. A – 29/1 GF Panchsheel Vihar Khirki Malviya Nagar, New Delhi, Delhi, India – 110017
- IndustryHealthcare, Medical Appliances And Instruments, Manufacturing
To see the full contact details of Corpus Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Corpus Pharmaceuticals India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Corpus Pharmaceuticals India Private Limited, buy the company report.
Financials of Corpus Pharmaceuticals India Private Limited
FY 2024 filings availableCorpus Pharmaceuticals India Private Limited reported revenue of ₹6.98 Lakh (up 100% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 100% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹6.98 Lakh | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹1,748 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹1,748 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -0.3% | |
| Net Profit Margin | -0.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Corpus Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Corpus Pharmaceuticals India Private Limited
Corpus Pharmaceuticals India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijender Singh | Director | 29 Jun 2021 | 5 Years 4 Months | Current |
| Prashant Also directs: Vedic Era Forest LLP, Rameti Energies Private Limited, Inline Visa Services Private Limited and 2 more | Director | 25 Sep 2018 | 8 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Corpus Pharmaceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Corpus Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Corpus Pharmaceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCC7619R1ZZ | Haryana | Active | 25 Jan 2019 |
To see the full GST registrations and return filing status of Corpus Pharmaceuticals India Private Limited, buy the company report.
Recent activity
Corpus Pharmaceuticals India Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Abhishek ceased to be Director on 30 Jun 2021.
Frequently asked questions
Corpus Pharmaceuticals India is an active private limited company based in New Delhi, Delhi, India. The company works in medical appliances and instruments, within the healthcare industry. It was incorporated on 25 September 2018 (8+ years old) and is registered under CIN U33100DL2018PTC339418.
Corpus Pharmaceuticals India has 2 current directors:
- Vijender Singh - Director
- Prashant - Director
The latest financial statements of Corpus Pharmaceuticals India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Corpus Pharmaceuticals India is 06AAHCC7619R1ZZ, registered in Haryana.
The CIN (Corporate Identification Number) of Corpus Pharmaceuticals India is U33100DL2018PTC339418. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Corpus Pharmaceuticals India was incorporated on 25 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Abhishek ceased to be Director on 30 Jun 2021. Vijender Singh was appointed as Director on 29 Jun 2021. Prashant was appointed as Director on 25 Sep 2018.
The registered office of Corpus Pharmaceuticals India is at H. No. A – 291 GF Panchsheel Vihar Khirki Malviya Nagar, New Delhi, Delhi, India – 110017.
Corpus Pharmaceuticals India operates in the healthcare industry, in the medical appliances and instruments segment.
Corpus Pharmaceuticals India can be reached at its registered office: H. No. A – 291 GF Panchsheel Vihar Khirki Malviya Nagar, New Delhi, Delhi, India – 110017.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
